STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #355 by analyst upside · 2026-06-27
DCGO
DocGo Inc.
Healthcare · Market Cap $48M · P/E 0x
ANALYST PRICE TARGET
+282.7%
implied upside to consensus target
Current Price $0.49
Consensus Target $1.88
Bull Target $3.0
Bear Target $1.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
1
Hold
2
Sell
0
52-Week Low $0.45
52-Week High $1.78
YTD Return -44.8%
FUNDAMENTALS
Market Cap $48M
P/E Ratio (TTM) N/A
Forward P/E 9.6x
EPS (TTM) $-1.90
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $302M
Profit Margin -62.2%
52-WEEK RANGE
52-Week Low $0.45
52-Week High $1.78
Current Price $0.49
Bear Target $1.0
Bull Target $3.0
● Now $0.49 ● Target $1.88
TRADING DATA
Avg Volume 1.0M
YTD Return -44.8%
Analyst Count 4
Consensus Buy
Upside to Target +282.7%
Last Updated 2026-06-27

ANALYST SUMMARY

DocGo Inc. (DCGO) is currently trading at $0.49 with a Wall Street consensus price target of $1.88, implying potential upside of 282.7% over the next 12 months. 4 analysts currently cover DCGO, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.0, while the most cautious has a target of $1.0.

DCGO operates in the Healthcare sector with a market capitalisation of $48M. The stock is down 44.8% year-to-date and is currently trading near the lower end of its 52-week range of $0.45 – $1.78.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for DCGO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Hold → Hold 2026-03-25 Building track record
Stifel — Reiterated
Buy → Buy 2026-03-17 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-03-17 40% win rate (10 calls)
Needham reit
Buy → Buy 2026-03-17 20% win rate (5 calls)
Canaccord Genuity — Reiterated
Hold → Hold 2025-11-12 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2025-08-21 Building track record
Canaccord Genuity ↓ Downgrade
Buy → Hold 2025-05-12 Building track record
Needham — Reiterated
Buy → Buy 2025-05-09 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
19
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →